AAPGV - Bathi operasional sadurunge ngurangi amortisasi Ascentage Pharma Group International
Ascentage Pharma Group is automating the search for oncoprotein inhibitors through robotic molecular design, eliminating manual labor. The cash EBITDA trend reflects the current financial result of operations, where the indicator value stands at 0.00. The company is minimizing lab technician involvement in tests by implementing software robots to process targeted therapy data sets and perform molecular screening.
Ascentage Pharma (AAPGV) - rincian metrik lan laporan keuangan
- kuotasi lan prakiraan analis:
- statistik kapitalisasi pasar:
- data nilai buku modal saham:
- indikator total utang lan likuiditas perusahaan:
Utang marang Modal Ascentage Pharma Group|AAPGV - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Ascentage Pharma Group International|AAPGV - Utang perusahaan|Utang-utang marang aset resik Ascentage Pharma|AAPGV - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Ascentage Pharma|Likuiditas darurat ascentage.com
- data bathi bisnis lan rasio investasi:
AAPGV - Bathi resik perusahaan|Prakiraan bathi resik Ascentage Pharma Group|AAPGV - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep ascentage.com|AAPGV - Pangali PEG|Pangali EV/EBITDA Ascentage Pharma|AAPGV - Bathi operasional EBITDA|Bathi resik saben saham sajroning taun lumaku Ascentage Pharma|AAPGV - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan ascentage.com|AAPGV - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep Ascentage Pharma Group
Analisis kabeh metrik perusahaan:AAPGV Ascentage
The investment attractiveness of Ascentage Pharma Group (AAPGV) is based on the international management's ability to monetize oncology developments in the Chinese and US markets. An analysis of absolute EBITDA allows for an assessment of the real efficiency of the operating cycle, excluding debt load and asset depreciation, confirming the business's financial stability amid the Fed's tight monetary policy.
Karo sapa Ascentage Pharma Group saingan
Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi ONC|Halozyme Therapeutics - Bathi operasional EBITDA|revmed.com (RVMD) - Bathi operasional sadurunge ngurangi amortisasi|AAPG (Ascentage Pharma) - Bathi operasional sadurunge ngurangi amortisasi|CG Oncology Inc (CGON) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi UroGen|BCAX: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA PSNL|ERAS - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi operasional EBITDA DCTH (Delcath Systems)|Bathi operasional EBITDA Y-mAbs Therapeutics Inc YMAB|AURA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi Candel Therapeutics CADL|ARAY: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi SELLAS Life Sciences Group|ACTU (Actuate Therapeutics) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Citius Oncology Inc. CTOR|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TuHURA Biosciences, Inc. (HURA)|Protara Tx - Bathi operasional sadurunge amortisasi|Fate Therapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi WHWK (Aadi Bioscience, Inc.)|TScan - Bathi operasional EBITDA|CSBR - Bathi operasional EBITDA|XBIT: Bathi operasional EBITDA|Bathi operasional sadurunge potongan amortisasi CEL-SCI CVM|OSTX (OS Therapies Incorporated) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi radiopharmtheranostics.com RADX|Bathi operasional sadurunge ngurangi amortisasi ARTV (Artiva Biotherapeutics, Inc.)|ANL (adlainortye.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Veru Pharma VERU|TPST (Tempest Therapeutics Corp) - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Xilio - Bathi operasional EBITDA|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi RENB (Renovaro Inc.)|MURA: Bathi operasional EBITDA|Kairos Pharma (KAPA) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi OnKure Therapeutics, Inc.|GDTC: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Curis, Inc. (CRIS)|Bathi operasional sadurunge ngurangi amortisasi apollomicsinc.com APLM|Bathi operasional EBITDA THAR (Tharimmune)|Bathi operasional EBITDA Advanced Biomed Inc. ADVB|GNPX: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi CLDI (Calidi Biotherapeutics)|SBFM: Bathi operasional EBITDA|Bathi operasional sadurunge potongan amortisasi Xenetic Biosciences, Inc. XBIO|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Salarius Pharmaceuticals, Inc.|PPBT: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi American Oncology Network (AONC)|BGNE - Bathi sadurunge bunga, pajak, lan amortisasi|Checkpoint Therapeutics - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA elevationoncology.com ELEV|ICAD - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi IKNA|NTBL: Bathi operasional EBITDA|Viracta Therapeutics, Inc. (VIRX) - Bathi operasional EBITDA|MOR (MorphoSys AG) - Bathi operasional EBITDA|Bathi operasional EBITDA nayabiosciences.com
